메뉴 건너뛰기




Volumn 21, Issue 1, 2007, Pages 89-101

Anti-inflammatory Strategies and Hemostatic Agents: Old Drugs, New Ideas

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; CLOPIDOGREL; CORTICOSTEROID; DESMOPRESSIN; HEMOSTATIC AGENT; KALLIKREIN INHIBITOR; PEXELIZUMAB; PLACEBO; TRANEXAMIC ACID;

EID: 33846551977     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.11.007     Document Type: Review
Times cited : (9)

References (55)
  • 1
    • 0035163406 scopus 로고    scopus 로고
    • Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
    • Despotis G.J., Avidan M.S., and Hogue Jr. C.W. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 72 (2001) S1821-S1831
    • (2001) Ann Thorac Surg , vol.72
    • Despotis, G.J.1    Avidan, M.S.2    Hogue Jr., C.W.3
  • 2
    • 22244467080 scopus 로고    scopus 로고
    • Coagulation activation and organ dysfunction following cardiac surgery
    • Dixon B., Santamaria J., and Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 128 (2005) 229-236
    • (2005) Chest , vol.128 , pp. 229-236
    • Dixon, B.1    Santamaria, J.2    Campbell, D.3
  • 3
    • 0141609935 scopus 로고    scopus 로고
    • Inflammation and thrombosis
    • Esmon C.T. Inflammation and thrombosis. J Thromb Haemost 1 (2003) 1343-1348
    • (2003) J Thromb Haemost , vol.1 , pp. 1343-1348
    • Esmon, C.T.1
  • 4
    • 7044262108 scopus 로고    scopus 로고
    • The impact of the inflammatory response on coagulation
    • Esmon C.T. The impact of the inflammatory response on coagulation. Thromb Res 114 (2004) 321-327
    • (2004) Thromb Res , vol.114 , pp. 321-327
    • Esmon, C.T.1
  • 5
    • 0032747159 scopus 로고    scopus 로고
    • Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery
    • Fransen E., Maessen J., Dentener M., et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 116 (1999) 1233-1239
    • (1999) Chest , vol.116 , pp. 1233-1239
    • Fransen, E.1    Maessen, J.2    Dentener, M.3
  • 6
    • 3342939227 scopus 로고    scopus 로고
    • Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes
    • Spiess B.D., Royston D., Levy J.H., et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44 (2004) 1143-1148
    • (2004) Transfusion , vol.44 , pp. 1143-1148
    • Spiess, B.D.1    Royston, D.2    Levy, J.H.3
  • 7
    • 0042536453 scopus 로고    scopus 로고
    • Novel pharmacologic approaches to reduce bleeding
    • Levy J.H. Novel pharmacologic approaches to reduce bleeding. Can J Anaesth 50 (2003) S26-S30
    • (2003) Can J Anaesth , vol.50
    • Levy, J.H.1
  • 8
    • 24944553374 scopus 로고    scopus 로고
    • Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation
    • Levy J.H. Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation. Am J Health Syst Pharm 62 (2005) S15-S19
    • (2005) Am J Health Syst Pharm , vol.62
    • Levy, J.H.1
  • 9
    • 0037312501 scopus 로고    scopus 로고
    • Inflammatory response to cardiopulmonary bypass
    • Levy J.H., and Tanaka K.A. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75 (2003) S715-S720
    • (2003) Ann Thorac Surg , vol.75
    • Levy, J.H.1    Tanaka, K.A.2
  • 10
    • 2942545798 scopus 로고    scopus 로고
    • Bidirectional relation between inflammation and coagulation
    • Levi M., van der Poll T., and Buller H.R. Bidirectional relation between inflammation and coagulation. Circulation 109 (2004) 2698-2704
    • (2004) Circulation , vol.109 , pp. 2698-2704
    • Levi, M.1    van der Poll, T.2    Buller, H.R.3
  • 11
    • 0034949659 scopus 로고    scopus 로고
    • Multiple organ dysfunction syndrome: a narrative review
    • Johnson D., and Mayers I. Multiple organ dysfunction syndrome: a narrative review. Can J Anaesth 48 (2001) 502-509
    • (2001) Can J Anaesth , vol.48 , pp. 502-509
    • Johnson, D.1    Mayers, I.2
  • 12
    • 0035118319 scopus 로고    scopus 로고
    • Aprotinin and the systemic inflammatory response after cardiopulmonary bypass
    • Mojcik C.F., and Levy J.H. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 71 (2001) 745-754
    • (2001) Ann Thorac Surg , vol.71 , pp. 745-754
    • Mojcik, C.F.1    Levy, J.H.2
  • 13
    • 0034053099 scopus 로고    scopus 로고
    • Pathophysiology of ischaemia-reperfusion injury
    • Carden D.L., and Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J Pathol 190 (2000) 255-266
    • (2000) J Pathol , vol.190 , pp. 255-266
    • Carden, D.L.1    Granger, D.N.2
  • 14
    • 0042474500 scopus 로고    scopus 로고
    • The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury
    • Mackman N. The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury. Semin Vasc Med 3 (2003) 193-198
    • (2003) Semin Vasc Med , vol.3 , pp. 193-198
    • Mackman, N.1
  • 15
    • 0037804799 scopus 로고    scopus 로고
    • Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass
    • Chandler W.L., and Velan T. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood 101 (2003) 4355-4362
    • (2003) Blood , vol.101 , pp. 4355-4362
    • Chandler, W.L.1    Velan, T.2
  • 16
    • 5644295330 scopus 로고    scopus 로고
    • Plasmin generation and D-dimer formation during cardiopulmonary bypass
    • Chandler W.L., and Velan T. Plasmin generation and D-dimer formation during cardiopulmonary bypass. Blood Coagul Fibrinolysis 15 (2004) 583-591
    • (2004) Blood Coagul Fibrinolysis , vol.15 , pp. 583-591
    • Chandler, W.L.1    Velan, T.2
  • 17
    • 23444439487 scopus 로고    scopus 로고
    • Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass
    • Chandler W.L. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 19 (2005) 459-467
    • (2005) J Cardiothorac Vasc Anesth , vol.19 , pp. 459-467
    • Chandler, W.L.1
  • 18
    • 0033584457 scopus 로고    scopus 로고
    • Disseminated intravascular coagulation
    • Levi M., and Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 341 (1999) 586-592
    • (1999) N Engl J Med , vol.341 , pp. 586-592
    • Levi, M.1    Ten Cate, H.2
  • 19
    • 1142309740 scopus 로고    scopus 로고
    • Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
    • Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61 (2004) 481-497
    • (2004) Cardiovasc Res , vol.61 , pp. 481-497
    • Vinten-Johansen, J.1
  • 20
    • 0037253347 scopus 로고    scopus 로고
    • Participation in inflammation
    • Coughlin S.R., and Camerer E. Participation in inflammation. J Clin Invest 111 (2003) 25-27
    • (2003) J Clin Invest , vol.111 , pp. 25-27
    • Coughlin, S.R.1    Camerer, E.2
  • 21
    • 28344436780 scopus 로고    scopus 로고
    • Protease-activated receptors in hemostasis, thrombosis and vascular biology
    • Coughlin S.R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3 (2005) 1800-1814
    • (2005) J Thromb Haemost , vol.3 , pp. 1800-1814
    • Coughlin, S.R.1
  • 22
    • 0033862187 scopus 로고    scopus 로고
    • The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1
    • Poullis M., Manning R., Laffan M., et al. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. J Thorac Cardiovasc Surg 120 (2000) 370-378
    • (2000) J Thorac Cardiovasc Surg , vol.120 , pp. 370-378
    • Poullis, M.1    Manning, R.2    Laffan, M.3
  • 23
    • 7544236615 scopus 로고    scopus 로고
    • Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery
    • Day J.R., Punjabi P.P., Randi A.M., et al. Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation 110 (2004) 2597-2600
    • (2004) Circulation , vol.110 , pp. 2597-2600
    • Day, J.R.1    Punjabi, P.P.2    Randi, A.M.3
  • 24
    • 30044439555 scopus 로고    scopus 로고
    • Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1
    • Day J.R., Taylor K.M., Lidington E.A., et al. Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1. J Thorac Cardiovasc Surg 131 (2006) 21-27
    • (2006) J Thorac Cardiovasc Surg , vol.131 , pp. 21-27
    • Day, J.R.1    Taylor, K.M.2    Lidington, E.A.3
  • 25
    • 4644360059 scopus 로고    scopus 로고
    • Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest
    • Khan T.A., Bianchi C., Voisine P., et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg 128 (2004) 602-608
    • (2004) J Thorac Cardiovasc Surg , vol.128 , pp. 602-608
    • Khan, T.A.1    Bianchi, C.2    Voisine, P.3
  • 26
    • 2442613898 scopus 로고    scopus 로고
    • Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial
    • Verrier E.D., Shernan S.K., Taylor K.M., et al. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 291 (2004) 2319-2327
    • (2004) JAMA , vol.291 , pp. 2319-2327
    • Verrier, E.D.1    Shernan, S.K.2    Taylor, K.M.3
  • 27
    • 3242769906 scopus 로고    scopus 로고
    • Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
    • Chong A.J., Shimamoto A., Hampton C.R., et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128 (2004) 170-179
    • (2004) J Thorac Cardiovasc Surg , vol.128 , pp. 170-179
    • Chong, A.J.1    Shimamoto, A.2    Hampton, C.R.3
  • 28
    • 0036305603 scopus 로고    scopus 로고
    • The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist
    • Laffey J.G., Boylan J.F., and Cheng D.C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97 (2002) 215-252
    • (2002) Anesthesiology , vol.97 , pp. 215-252
    • Laffey, J.G.1    Boylan, J.F.2    Cheng, D.C.3
  • 29
    • 0035171792 scopus 로고    scopus 로고
    • Pharmacologic preservation of the hemostatic system during cardiac surgery
    • Levy J.H. Pharmacologic preservation of the hemostatic system during cardiac surgery. Ann Thorac Surg 72 (2001) S1814-S1820
    • (2001) Ann Thorac Surg , vol.72
    • Levy, J.H.1
  • 30
    • 4444380033 scopus 로고    scopus 로고
    • Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials
    • Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
    • (2004) J Thorac Cardiovasc Surg , vol.128 , pp. 442-448
    • Sedrakyan, A.1    Treasure, T.2    Elefteriades, J.A.3
  • 31
    • 0036203002 scopus 로고    scopus 로고
    • Corticosteroids and cardiopulmonary bypass: a review of clinical investigations
    • Chaney M.A. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest 121 (2002) 921-931
    • (2002) Chest , vol.121 , pp. 921-931
    • Chaney, M.A.1
  • 32
    • 0033854191 scopus 로고    scopus 로고
    • An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation
    • Asimakopoulos G., Thompson R., Nourshargh S., et al. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg 120 (2000) 361-369
    • (2000) J Thorac Cardiovasc Surg , vol.120 , pp. 361-369
    • Asimakopoulos, G.1    Thompson, R.2    Nourshargh, S.3
  • 33
    • 0028792021 scopus 로고
    • A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting
    • Levy J.H., Pifarre R., Schaff H.V., et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 92 (1995) 2236-2244
    • (1995) Circulation , vol.92 , pp. 2236-2244
    • Levy, J.H.1    Pifarre, R.2    Schaff, H.V.3
  • 34
    • 24644522766 scopus 로고    scopus 로고
    • Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial
    • van der Linden J., Lindvall G., and Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation 112 Suppl 9 (2005) I276-I280
    • (2005) Circulation , vol.112 , Issue.SUPPL. 9
    • van der Linden, J.1    Lindvall, G.2    Sartipy, U.3
  • 35
    • 0035656032 scopus 로고    scopus 로고
    • The antithrombotic and antiinflammatory mechanisms of action of aprotinin
    • Landis R.C., Asimakopoulos G., Poullis M., et al. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg 72 (2001) 2169-2175
    • (2001) Ann Thorac Surg , vol.72 , pp. 2169-2175
    • Landis, R.C.1    Asimakopoulos, G.2    Poullis, M.3
  • 36
    • 0035171791 scopus 로고    scopus 로고
    • New antiinflammatory and platelet-preserving effects of aprotinin
    • Landis R.C., Haskard D.O., and Taylor K.M. New antiinflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg 72 (2001) S1808-S1813
    • (2001) Ann Thorac Surg , vol.72
    • Landis, R.C.1    Haskard, D.O.2    Taylor, K.M.3
  • 37
    • 29244458636 scopus 로고    scopus 로고
    • Transfusion immunomodulation or TRIM: what does it mean clinically?
    • Blajchman M.A. Transfusion immunomodulation or TRIM: what does it mean clinically?. Hematology 10 Suppl 1 (2005) 208-214
    • (2005) Hematology , vol.10 , Issue.SUPPL. 1 , pp. 208-214
    • Blajchman, M.A.1
  • 38
    • 15244343326 scopus 로고    scopus 로고
    • Transfusion-related acute lung injury
    • Silliman C.C., Ambruso D.R., and Boshkov L.K. Transfusion-related acute lung injury. Blood 105 (2005) 2266-2273
    • (2005) Blood , vol.105 , pp. 2266-2273
    • Silliman, C.C.1    Ambruso, D.R.2    Boshkov, L.K.3
  • 39
    • 0033788443 scopus 로고    scopus 로고
    • Transfusion-related acute lung injury
    • Popovsky M.A. Transfusion-related acute lung injury. Curr Opin Hematol 7 (2000) 402-407
    • (2000) Curr Opin Hematol , vol.7 , pp. 402-407
    • Popovsky, M.A.1
  • 40
    • 0033524140 scopus 로고    scopus 로고
    • Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints
    • [see comment]
    • Levi M., Cromheecke M.E., de Jonge E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. [see comment]. Lancet 354 (1999) 1940-1947
    • (1999) Lancet , vol.354 , pp. 1940-1947
    • Levi, M.1    Cromheecke, M.E.2    de Jonge, E.3
  • 41
    • 0035230145 scopus 로고    scopus 로고
    • Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
    • CD001886
    • Henry D.A., Moxey A.J., Carless P.A., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2001) CD001886
    • (2001) Cochrane Database Syst Rev
    • Henry, D.A.1    Moxey, A.J.2    Carless, P.A.3
  • 42
    • 30944448194 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery
    • [quiz: A44-5]
    • Kikura M., Levy J.H., Tanaka K.A., et al. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. J Am Coll Surg 202 (2006) 216-222 [quiz: A44-5]
    • (2006) J Am Coll Surg , vol.202 , pp. 216-222
    • Kikura, M.1    Levy, J.H.2    Tanaka, K.A.3
  • 43
    • 31344467254 scopus 로고    scopus 로고
    • The risk associated with aprotinin in cardiac surgery
    • Mangano D.T., Tudor I.C., and Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006) 353-365
    • (2006) N Engl J Med , vol.354 , pp. 353-365
    • Mangano, D.T.1    Tudor, I.C.2    Dietzel, C.3
  • 44
    • 33646365664 scopus 로고    scopus 로고
    • Aprotinin in cardiac surgery
    • [author reply: 1953-7]
    • Levy J.H., Ramsay J.G., and Guyton R.A. Aprotinin in cardiac surgery. N Engl J Med 354 (2006) 1953-1957 [author reply: 1953-7]
    • (2006) N Engl J Med , vol.354 , pp. 1953-1957
    • Levy, J.H.1    Ramsay, J.G.2    Guyton, R.A.3
  • 46
    • 3543135271 scopus 로고    scopus 로고
    • Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    • D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
    • (1998) Stat Med , vol.17 , pp. 2265-2281
    • D'Agostino Jr., R.B.1
  • 47
    • 0025805153 scopus 로고
    • Channeling bias in the interpretation of drug effects
    • Petri H., and Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med 10 (1991) 577-581
    • (1991) Stat Med , vol.10 , pp. 577-581
    • Petri, H.1    Urquhart, J.2
  • 48
    • 0025793562 scopus 로고
    • Problems with using observational databases to compare treatments
    • Byar D.P. Problems with using observational databases to compare treatments. Stat Med 10 (1991) 663-666
    • (1991) Stat Med , vol.10 , pp. 663-666
    • Byar, D.P.1
  • 49
    • 9544228424 scopus 로고    scopus 로고
    • The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators
    • Connors Jr. A.F., Speroff T., Dawson N.V., et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276 (1996) 889-897
    • (1996) JAMA , vol.276 , pp. 889-897
    • Connors Jr., A.F.1    Speroff, T.2    Dawson, N.V.3
  • 50
    • 33644680067 scopus 로고    scopus 로고
    • A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery
    • Karkouti K., Beattie W.S., Dattilo K.M., et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 46 (2006) 327-338
    • (2006) Transfusion , vol.46 , pp. 327-338
    • Karkouti, K.1    Beattie, W.S.2    Dattilo, K.M.3
  • 51
    • 33644861224 scopus 로고    scopus 로고
    • Improving the identification of patients at risk of postoperative renal failure after cardiac surgery
    • Wijeysundera D.N., Karkouti K., Beattie W.S., et al. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 104 (2006) 65-72
    • (2006) Anesthesiology , vol.104 , pp. 65-72
    • Wijeysundera, D.N.1    Karkouti, K.2    Beattie, W.S.3
  • 52
    • 25144454447 scopus 로고    scopus 로고
    • Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
    • [discussion: 1393]
    • Kincaid E.H., Ashburn D.A., Hoyle J.R., et al. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?. Ann Thorac Surg 80 (2005) 1388-1393 [discussion: 1393]
    • (2005) Ann Thorac Surg , vol.80 , pp. 1388-1393
    • Kincaid, E.H.1    Ashburn, D.A.2    Hoyle, J.R.3
  • 53
    • 33846511903 scopus 로고    scopus 로고
    • FDA Public Health Advisory. Available at: http://www.fda.gov/bbs/topics/news/2006/NEW01311.html. Accessed February 8, 2006.
  • 54
    • 0031663326 scopus 로고    scopus 로고
    • Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations
    • discussion 541
    • Miller B.E., Tosone S.R., Tam V.K., et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 66 2 (1998) 535-540 discussion 541
    • (1998) Ann Thorac Surg , vol.66 , Issue.2 , pp. 535-540
    • Miller, B.E.1    Tosone, S.R.2    Tam, V.K.3
  • 55
    • 0442292366 scopus 로고    scopus 로고
    • Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials
    • discussion 642-3
    • Smith P.K., Datta S.K., Muhlbaier L.H., et al. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. Ann Thorac Surg 77 2 (2004) 635-642 discussion 642-3
    • (2004) Ann Thorac Surg , vol.77 , Issue.2 , pp. 635-642
    • Smith, P.K.1    Datta, S.K.2    Muhlbaier, L.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.